DE69922787D1 - N,n'-bis(2-hydroxybenzyl)ethylendiamin-n,n'-diessigsäure und natriumsalze davon zur eisenchelatierungstherapie - Google Patents
N,n'-bis(2-hydroxybenzyl)ethylendiamin-n,n'-diessigsäure und natriumsalze davon zur eisenchelatierungstherapieInfo
- Publication number
- DE69922787D1 DE69922787D1 DE69922787T DE69922787T DE69922787D1 DE 69922787 D1 DE69922787 D1 DE 69922787D1 DE 69922787 T DE69922787 T DE 69922787T DE 69922787 T DE69922787 T DE 69922787T DE 69922787 D1 DE69922787 D1 DE 69922787D1
- Authority
- DE
- Germany
- Prior art keywords
- hydroxybenzyl
- ethylenediamine
- bis
- diacetic acid
- sodium salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- GRUVVLWKPGIYEG-UHFFFAOYSA-N 2-[2-[carboxymethyl-[(2-hydroxyphenyl)methyl]amino]ethyl-[(2-hydroxyphenyl)methyl]amino]acetic acid Chemical compound C=1C=CC=C(O)C=1CN(CC(=O)O)CCN(CC(O)=O)CC1=CC=CC=C1O GRUVVLWKPGIYEG-UHFFFAOYSA-N 0.000 title abstract 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 4
- 229910052742 iron Inorganic materials 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- NOJNFULGOQGBKB-UHFFFAOYSA-M sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate Chemical compound [Na+].C1=NC(OCC)=CC=C1C(C=C1)=CC=C1CN1C2=CC=C(OCC=3N=CC(C)=CC=3)C=C2C(SC(C)(C)C)=C1CC(C)(C)C([O-])=O NOJNFULGOQGBKB-UHFFFAOYSA-M 0.000 title 1
- 206010065973 Iron Overload Diseases 0.000 abstract 2
- 125000002091 cationic group Chemical group 0.000 abstract 1
- OEUUFNIKLCFNLN-LLVKDONJSA-N chembl432481 Chemical compound OC(=O)[C@@]1(C)CSC(C=2C(=CC(O)=CC=2)O)=N1 OEUUFNIKLCFNLN-LLVKDONJSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- -1 iron overload Chemical compound 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7360398P | 1998-02-04 | 1998-02-04 | |
US73603P | 1998-02-04 | ||
PCT/US1999/002388 WO1999039706A1 (en) | 1998-02-04 | 1999-02-03 | Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl) ethylenediamine-n, n'-diacetic acid for iron chelating therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69922787D1 true DE69922787D1 (de) | 2005-01-27 |
DE69922787T2 DE69922787T2 (de) | 2005-12-15 |
Family
ID=22114691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69922787T Expired - Lifetime DE69922787T2 (de) | 1998-02-04 | 1999-02-03 | N,n'-bis(2-hydroxybenzyl)ethylendiamin-n,n'-diessigsäure und natriumsalze davon zur eisenchelatierungstherapie |
Country Status (13)
Country | Link |
---|---|
US (2) | US6242492B1 (de) |
EP (1) | EP1052985B1 (de) |
JP (1) | JP2002502816A (de) |
CN (1) | CN1227006C (de) |
AT (1) | ATE285232T1 (de) |
AU (1) | AU752383B2 (de) |
CA (1) | CA2319255C (de) |
DE (1) | DE69922787T2 (de) |
ES (1) | ES2235461T3 (de) |
NZ (1) | NZ506528A (de) |
PT (1) | PT1052985E (de) |
TR (1) | TR200002256T2 (de) |
WO (1) | WO1999039706A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7232830B2 (en) * | 1998-06-26 | 2007-06-19 | Elaine A Delack | Method for treatment of neurodegenerative diseases and effects of aging |
AU770999C (en) | 1999-10-01 | 2005-04-21 | Ampio Pharmaceuticals, Inc. | Metal-binding compounds and uses therefor |
CA2394524A1 (en) * | 1999-12-21 | 2001-06-28 | Raymond J. Bergeron | N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy |
US7160855B2 (en) * | 2002-03-14 | 2007-01-09 | Children's Hospital & Research Center At Oakland | Enhancement of iron chelation therapy |
TR201910900T4 (tr) * | 2005-04-04 | 2019-08-21 | Univ Florida | Desferritiyokin polieter analogları. |
US8623661B2 (en) | 2008-09-22 | 2014-01-07 | National University Corporation Asahikawa Medical College | Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions |
WO2010133907A1 (en) * | 2009-05-18 | 2010-11-25 | Carlo Ghisalberti | Hexadentate chelators in inflammatory bowel disease |
US8378134B2 (en) * | 2009-09-30 | 2013-02-19 | General Electric Company | Hydroxylated contrast enhancement agents |
US20110077417A1 (en) * | 2009-09-30 | 2011-03-31 | General Electric Company | Intermediates for Hydroxylated Contrast Enhancement Agents |
US20110077396A1 (en) * | 2009-09-30 | 2011-03-31 | General Electric Company | Intermediates for hydroxylated contrast enhancement agents |
EP2664333B1 (de) | 2011-01-14 | 2016-10-12 | Disease Adsorption System Technologies Co., Ltd. | Polymere eisenchelatbildner |
WO2012104204A1 (en) | 2011-01-31 | 2012-08-09 | Vifor (International) Ag | Iron-carbohydrate complex compounds for the intravenous therapy of malaria |
CN104706631A (zh) * | 2013-12-14 | 2015-06-17 | 于莹莹 | 一种铁螯合剂作为制备抗癌药物的应用 |
MX2017016399A (es) | 2015-06-25 | 2018-03-02 | Akzo Nobel Chemicals Int Bv | Proceso para preparar compuestos de acido etilendiaminodiacetico fenolico. |
PL3313813T3 (pl) | 2015-06-25 | 2019-10-31 | Akzo Nobel Chemicals Int Bv | Sposób wytwarzania związków fenolowego kwasu etylenodiaminodioctowego |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3005848A (en) | 1957-09-09 | 1961-10-24 | Geigy Chem Corp | Ethylenediamine derivatives containing aromatic rings |
US3758540A (en) | 1968-02-13 | 1973-09-11 | A Martell | Ferric chelates of n-(2-hydroxybenzyl) substituted aminopoly carboxylic acids |
BE786946A (fr) | 1971-07-29 | 1973-01-29 | Ciba Geigy | Chelates pour combattre des symptomes de carences en metaux dans des systemes biologiques |
GB1439048A (en) | 1973-09-11 | 1976-06-09 | Ciba Geigy Ag | Metal complexes of bis-azomethines and processes for their manufacture |
FR2267308B1 (de) | 1974-04-12 | 1976-10-08 | Protex Manuf Prod Chimiq | |
CH602857A5 (de) | 1976-12-10 | 1978-08-15 | Ciba Geigy Ag | |
US4130582A (en) | 1977-04-19 | 1978-12-19 | Ciba-Geigy Corporation | Preparation of phenolic ethylenediaminepolycarboxylic acids |
US4352751A (en) | 1979-09-10 | 1982-10-05 | Analytical Radiation Corporation | Species-linked diamine triacetic acids and their chelates |
US4528196A (en) * | 1981-02-23 | 1985-07-09 | The United States Of America As Represented By The Department Of Health And Human Services | Chelating agents for the treatment of iron overload |
US4647447A (en) | 1981-07-24 | 1987-03-03 | Schering Aktiengesellschaft | Diagnostic media |
US4454106A (en) | 1982-06-07 | 1984-06-12 | Gansow Otto A | Use of metal chelate conjugated monoclonal antibodies |
US4909257A (en) | 1986-05-01 | 1990-03-20 | The Regents Of The University Of California | Method for attaining in vivo tissue-specific contrast by nuclear magnetic resonance imaging |
US5227474A (en) * | 1987-02-13 | 1993-07-13 | Abbott Laboratories | Bifunctional chelating agents |
US5057302A (en) * | 1987-02-13 | 1991-10-15 | Abbott Laboratories | Bifunctional chelating agents |
PH31170A (en) | 1988-10-31 | 1998-03-20 | Dow Chemical Co | Chelants possesing ortho ligating functionality and complexes thereof. |
US5376154A (en) | 1991-05-13 | 1994-12-27 | The Lubrizol Corporation | Low-sulfur diesel fuels containing organometallic complexes |
US5840739A (en) * | 1992-11-16 | 1998-11-24 | University Of Florida Research Foundation, Inc. | Thiazoline acid derivatives |
US5534241A (en) * | 1993-07-23 | 1996-07-09 | Torchilin; Vladimir P. | Amphipathic polychelating compounds and methods of use |
CA2179203A1 (en) * | 1993-12-16 | 1995-06-22 | Fabrizio Gasparini | N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents |
US5539138A (en) | 1994-07-28 | 1996-07-23 | Merck Frosst Canada, Inc. | High affinity chelates containing isothiocyanate groups, useful for coupling with peptides and proteins |
WO1997044313A1 (en) | 1996-05-21 | 1997-11-27 | Novartis Ag | N,N'-Di(2-HYDROXYBENZYL)ETHYLENEDIAMINE-N,N'-DIACETIC ACID DERIVATIVES |
-
1999
- 1999-02-03 PT PT99905716T patent/PT1052985E/pt unknown
- 1999-02-03 NZ NZ506528A patent/NZ506528A/xx not_active IP Right Cessation
- 1999-02-03 ES ES99905716T patent/ES2235461T3/es not_active Expired - Lifetime
- 1999-02-03 CA CA2319255A patent/CA2319255C/en not_active Expired - Fee Related
- 1999-02-03 DE DE69922787T patent/DE69922787T2/de not_active Expired - Lifetime
- 1999-02-03 WO PCT/US1999/002388 patent/WO1999039706A1/en active IP Right Grant
- 1999-02-03 AT AT99905716T patent/ATE285232T1/de not_active IP Right Cessation
- 1999-02-03 CN CNB998027219A patent/CN1227006C/zh not_active Expired - Fee Related
- 1999-02-03 AU AU25814/99A patent/AU752383B2/en not_active Ceased
- 1999-02-03 JP JP2000530205A patent/JP2002502816A/ja active Pending
- 1999-02-03 EP EP99905716A patent/EP1052985B1/de not_active Expired - Lifetime
- 1999-02-03 TR TR2000/02256T patent/TR200002256T2/xx unknown
- 1999-12-21 US US09/467,943 patent/US6242492B1/en not_active Expired - Lifetime
-
2000
- 2000-11-28 US US09/724,823 patent/US6531510B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1290163A (zh) | 2001-04-04 |
US6531510B1 (en) | 2003-03-11 |
AU752383B2 (en) | 2002-09-19 |
PT1052985E (pt) | 2005-04-29 |
TR200002256T2 (tr) | 2001-03-21 |
EP1052985A1 (de) | 2000-11-22 |
ATE285232T1 (de) | 2005-01-15 |
DE69922787T2 (de) | 2005-12-15 |
JP2002502816A (ja) | 2002-01-29 |
CA2319255A1 (en) | 1999-08-12 |
CA2319255C (en) | 2010-01-26 |
CN1227006C (zh) | 2005-11-16 |
NZ506528A (en) | 2002-11-26 |
US6242492B1 (en) | 2001-06-05 |
AU2581499A (en) | 1999-08-23 |
WO1999039706A1 (en) | 1999-08-12 |
ES2235461T3 (es) | 2005-07-01 |
WO1999039706A9 (en) | 2000-09-21 |
EP1052985B1 (de) | 2004-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69922787D1 (de) | N,n'-bis(2-hydroxybenzyl)ethylendiamin-n,n'-diessigsäure und natriumsalze davon zur eisenchelatierungstherapie | |
HK1055721A1 (en) | Compounds to treat alzheimer's disease. | |
AU2001252958A1 (en) | Compounds and methods to treat alzheimer's disease | |
WO2002002520A8 (en) | Compounds to treat alzheimer's disease | |
WO2002002512A3 (en) | Compounds to treat alzheimer's disease | |
TR200200706T2 (tr) | Nöropatik ağrı tedavisi için retigabin kullanımı. | |
GB0225474D0 (en) | Therapeutic agents | |
AU5584901A (en) | Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease | |
NZ335981A (en) | Ketobenzamides as calpain inhibitors | |
BRPI0316438C1 (pt) | uso de eritropoietina em doenças cardíacas | |
MXPA04003796A (es) | Tioacetamidas sustituidas. | |
DE60322121D1 (de) | Zusammensetzung zur verabreichung von eisen für die behandlung des unruhigen beinsyndroms | |
IL162384A0 (en) | Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases | |
RS8504A (en) | Novel cyclohexil sulphones | |
AU2456201A (en) | N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy | |
MY118244A (en) | Alfa-amino acid amides, preparation thereof and the therapeutical use thereof | |
WO1999011256A8 (fr) | L-threonate ferreux, composition pharmaceutique le contenant et son utilisation pour reduire et traiter l'anemie chez l'homme | |
MXPA03005903A (es) | DISEnO Y USO DE PEPTIDOS QUELATANTES DE ZINC AVANZADOR PARA REGULAR LAS METALOPROTEINASAS DE MATRIZ. | |
ATE298581T1 (de) | Zusammensetzungen enthaltend eisenerz zur topischen behandlung von bioenergetischen und elektromagnetischen erkrankungen | |
MY122576A (en) | Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect | |
UY27475A1 (es) | Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización | |
DE60108775T8 (de) | Methode zur behandlung von schlaganfall | |
ES2190373A1 (es) | Uso del acido 2-hidroxi- o 2-acetiloxi-4-trifluorometilbenzoico como agente para el tratamiento y prevencion del deterioro cognitivo ligero. | |
UA42427A (uk) | Спосіб корекції целюліту та/або локальних жирових відкладень | |
UA64813C2 (uk) | Інтраназальний антисептик |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |